Arca
Skip to content
Tools
Tools

Meningioma

Drug research and approvals for meningioma: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 64 studies of meningioma are recruiting on ClinicalTrials.gov, Health Canada has authorized 1 drug trials for it since 2013, and FDA has 0 approved and 1 open orphan designations naming it.

  • Recruiting worldwide: 64
  • Trials authorized in Canada: 1
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 64 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Phase 3 3

Phase 2 12 of 22

Phase 1 or earlier 6

  • PioglitazonePeroxisome proliferator-activated receptor gamma agonist
  • ErlotinibEpidermal growth factor receptor erbB1 inhibitor
  • TrametinibDual specificity mitogen-activated protein kinase kinase 2 inhibitor
  • AlpelisibPI3-kinase p110-alpha subunit inhibitor
  • AvelumabProgrammed cell death 1 ligand 1 other
  • Dordaviprone

How its trials ended

195 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 27 whose ending is known, 15% met their primary endpoint, 7% missed it and 78% stopped early.

  • Ongoing8242%
  • Completed, result not reported6533%
  • Status unknown2111%
  • Stopped: other or unclear95%
  • Stopped: enrollment or feasibility84%
  • Met its primary endpoint42%
  • Missed its primary endpoint21%
  • Stopped: lack of efficacy21%
  • Stopped: sponsor or business decision21%

Trials authorized in Canada

Newest first; search them all in Canada trials
AuthorizedTrialSponsorStatus
Jun 29, 2026Ceritinib use for IGF1-receptor inhibition in meningioma – a phase 2 open- label study in recurrent grade 1 and 2 tumorsCeritinibMcGill UniversityPending

FDA orphan designations

Approved first, then open designations, newest first
DateDrugSponsorStatus
Nov 12, 20205-aminolevulinic acidDiagnostic for the visualization of tumor tissue in patients undergoing surgical resection for meningiomaNX Development Corp.Designated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.